Non-oncological pathology of the esogastric junction (EGJ) is an area of interdisciplinary interest for many practitioners (endoscopist, gastroenterologist, surgeon, radiologist). This is due to the increased incidence of esogastric junction benign pathology, especially gastroesophageal reflux disease (GERD), currently considered the disease of the 21st century. The overall incidence of GERD is increasing annually. Meta-analyses show the prevalence of this pathology in Western countries of about 10-20%, compared to Asian countries where it is below 10%, in North America of 27.8%, and 25.9% in Europe (1,2,3). Material and The experience of our department in antireflux surgery represents 20 years (2002-2021) of activity, during this time 768 antireflux interventions were performed for GERD and hiatal hernias (HH). Patients selected for antireflux surgery initially underwent conservative treatment in accordance with applicable international protocols. Approximately 40% of all patients were unwilling to undergo conservative antireflux treatment, and these data are in line with the world literature statistic (4). Moreover, the symptoms of gastroesophageal reflux disease in 24.2% of cases appeared one month after the end of conservative treatment, and in 35.8% after 6 months. The type of antireflux surgery in this period of activity was different and depended on the situation: the individual characteristics of the patient, different approaches to surgical techniques over different periods of time. Laparoscopic antireflux operations predominate in the majority of patients (96.6%) in the last 10 years, compared to previous years, where the rate of traditional interventions was 15-20. The complete fundoplication Nissen-Rossetti, due to the good control of GERD, has become an intervention of choice mainly for patients with GERD. 1. Early diagnosis of refractory forms to medical treatment requires referral of patients to laparoscopic antireflux surgery to avoid severe complications of GERD. 2. The minimally invasive approach to antireflux surgery today is a golden standard, and the use of a complete fundoplication ensures the high effectiveness of these interventions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.21614/chirurgia.2707 | DOI Listing |
J Am Coll Surg
January 2025
Prisma Health Upstate Department of Surgery, Greenville, SC.
Background: The concomitant hiatal hernia repair with endoscopic fundoplication (c-TIF) is a novel anti-reflux procedure that addresses the hiatus and the gastro-esophageal flap valve for surgical candidates with GERD. We aim to compare the outcomes of a hiatal hernia repair with endoscopic fundoplication (TIF) vs surgical partial fundoplication (anterior and posterior) with regards to quality-of-life scores at 12 months after surgery.
Study Design: Following IRB approval, a prospectively maintained anti-reflux database was retrospectively reviewed to identify patients who underwent a c-TIF procedure or a surgical hiatal hernia repair with partial fundoplication.
Surg Today
January 2025
Department of Gastroenterological Surgery, Hyogo Medical University, 1-1 Mukogawa, Nishinomiya, Hyogo, 663-8501, Japan.
Purpose: The double-flap technique (DFT) is an anti-reflux reconstruction procedure performed after proximal gastrectomy (PG), but its complexity and high incidence of anastomotic stenosis are problematic. We conducted this study to demonstrate the efficacy of robot-assisted DFT, with refinements, to address these issues.
Methods: Surgical outcomes were compared between the following procedures modified over time at our institution: conventional open DFT (group O, n = 16); early robotic DFT (group RE, n = 19), which follows the conventional open PG approach; and late robotic DFT (group RL, n = 21), which incorporates refinements to the early robotic DFT technique by exploiting more of the robotic capabilities available.
BMJ Open
December 2024
Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China
Introduction: Endoscopic antireflux therapy has shown promising potential in the treatment for gastro-oesophageal reflux disease (GERD). However, there is currently no universally accepted standard for endoscopic surgery. Therefore, we introduced antireflux mucosal valvuloplasty (ARMV), an innovative endoscopic treatment for GERD.
View Article and Find Full Text PDFSurg Endosc
January 2025
Faculty of Medicine, Pediatric Surgery, Tanta University Hospital, Tanta, 31527, Egypt.
Background: Surgical fundoplication remains integral in managing gastroesophageal reflux disease (GERD) by addressing gastroesophageal valve incompetence. This study introduces a novel hybrid approach, the Eversion Cruroplasty and Collar Overwrap (ECCO) procedure, aiming to combine benefits of conventional partial wrapping and posteromedial cardiopexy, considering gastric fundus anatomical peculiarities as an anti-reflux barrier.
Methods: A retrospective analysis of pediatric patients presenting with refractory GERD from 2021 to 2023 was conducted.
Several reconstruction methods are used in proximal gastrectomy. Esophagogastrostomy is the simplest and most physiological. The challenge in esophagogastrostomy is preventing reflux esophagitis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!